Atacicept
- Generic Name
- Atacicept
- Drug Type
- Biotech
- CAS Number
- 845264-92-8
- Unique Ingredient Identifier
- K3D9A0ICQ3
Overview
Atacicept is a recombinant fusion protein combined with the extracellular ligand binding portion of TACI.
Background
Atacicept is a recombinant fusion protein combined with the extracellular ligand binding portion of TACI.
Indication
Investigated for use/treatment in autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, multiple myeloma, lymphoma (non-hodgkin's), and leukemia (lymphoid).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath